Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Svedsater, Henrik ^a   Dale, Peter ^b   Garrill, Karl ^a   Walker, Richard ^a   Woepse, Mark W ^c  

^a GLAXOSMITHKLINE   (United Kingdom)

^b HEOR Solutions   (United Kingdom)

^c Strategic Eye Inc   (United States)

Author keywords

Ease of use; ELLIPTA inhaler; Inhaled therapy; Inhaler preference; Patient interviews

Indexed keywords

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTENT ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; DRY POWDER INHALER; ERGONOMICS; HUMAN; MAINTENANCE THERAPY; MEDICATION COMPLIANCE; METERED DOSE INHALER; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL; QUALITATIVE ANALYSIS; SEMI STRUCTURED INTERVIEW;

ADULT; ASTHMA; DRY POWDER INHALERS; EQUIPMENT DESIGN; HUMAN ENGINEERING; HUMANS; INTERVIEWS AS TOPIC; MAINTENANCE CHEMOTHERAPY; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT PREFERENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITATIVE RESEARCH;

EID: 84889041619     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-72     Document Type: Article

References (38)

1. Demoly P, Annunziata K, Gubba E, Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev 2012, 21:66-74. 10.1183/09059180.00008111, 22379176.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence and future trends. Lancet 2007, 370:765-773. 10.1016/S0140-6736(07)61380-4, 17765526.
3. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004, 3:191-195.
4. Lareau SC, Yawn BP. Improving adherence with inhaler therapy in COPD. Int J COPD 2010, 5:401-406.
5. Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention Updated 2012 Available at: http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html. Accessed: 2 October 2013, Global Initiative for Asthma (GINA).
6. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines on COPD Diagnosis, Prevention and Management. Updated 2013 Available at: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed: 2 October 2013, Global Initiative for Chronic Obstructive Lung Disease (GOLD).
7. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, Corrigan C, Levy M, Crompton GK. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008, 102:593-604. 10.1016/j.rmed.2007.11.003, 18083019.
8. Virchow JC, Crompton GK. Dal Negro R, Pedersen S, Magnan A, Seidenberg J, Barnes PJ: Importance of inhaler devices in the management of airway disease. Respir Med 2008, 102:10-19. 10.1016/j.rmed.2007.07.031, 17923402.
9. Small M, Anderson P, Vickers A, Kay S, Fermer S. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Ther 2011, 28:202-212. 10.1007/s12325-010-0108-4, 21331556.
10. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, Scichilone N, Sestini P, Aliani M, Neri M. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011, 105:930-938. 10.1016/j.rmed.2011.01.005, 21367593.
11. Vestbo J, Anderson JA, Calverley PMA, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009, 64:939-943. 10.1136/thx.2009.113662, 19703830.
12. Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, Moffat M, Versnel J, Shanahan ER, Hillyer EV, Tunsäter A, Bjermer L. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008, 102:1681-1693. 10.1016/j.rmed.2008.08.003, 18815019.
13. Price D, Robertson A, Bullen K, Rand C, Horne R, Staudinger H. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. BMC Pulm Med 2010, 10:1. 10.1186/1471-2466-10-1, 2822814, 20051135.
14. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008, 63:831-838. 10.1136/thx.2007.086041, 18728206.
15. Charles MS, Blanchette CM, Silver H, Lavallee D, Dalal AA, Mapel D. Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin 2010, 26:2421-2429. 10.1185/03007995.2010.516284, 20815661.
16. Emilsson M, Berndtsson I, Lötvall J, Millqvist E, Lundgren J, Johansson T, Brink E. The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Prim Care Respir J 2011, 20:141-147. 10.4104/pcrj.2011.00005, 21311839.
17. Dekhuijzen R, Magnan A, Kneussl M. The ADMIT series - issues in inhalation therapy. 1) The goals of asthma treatment - can they be achieved?. Prim Care Respir J 2007, 16:341-348.
18. Morris NR, Sabapathy S, Adams L, Kingsley RA, Schneider DA, Stulbarg MS. Verbal numerical scales are as reliable and sensitive as visual analog scales for rating dyspnea in young and older subjects. Respir Physiol Neurobiol 2007, 157:360-365. 10.1016/j.resp.2007.01.006, 17303478.
19. Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nursing 2008, 62:107-115.
20. Sandelowski M. Whatever happened to qualitative description?. Res Nurs Health 2000, 23:334. 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G, 10940958.
21. Capstick TGD, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med 2012, 6:91-103. 10.1586/ers.11.89, 22283582.
22. Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, Bousquet J. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med 2013, 107:37-46. 10.1016/j.rmed.2012.09.017, 23098685.
23. Papi A, Haughney J, Virchow JC, Roche N, Palkonen S, Price D. Inhaler devices for asthma: a call for action in a neglected field. Eur Respir J 2011, 37:982-985. 10.1183/09031936.00150910, 21532013.
24. Leiva-Fernández F, Leiva-Fernández J, Zubeldia-Santoyo F, García-Ruiz A, Prados-Torres D, Barnestein-Fonseca P. Efficacy of two educational interventions about inhalation techniques in patients with chronic obstructive pulmonary disease (COPD). TECEPOC: study protocol for a partially randomized controlled trial (preference trial). Trials 2012, 13:64. 10.1186/1745-6215-13-64, 3404981, 22613015.
25. Horne R. Adherence to asthma medication: a question of ability?. Prim Care Respir J 2011, 20:118-119. 10.4104/pcrj.2011.00054, 21597663.
26. Roy A, Battle K, Lurslurchachai L, Halm EA, Wisnivesky JP. Inhaler device, administration technique, and adherence to inhaled corticosteroids in patients with asthma. Prim Care Respir J 2011, 20:148-154. 10.4104/pcrj.2011.00022, 21437565.
27. World Health Organization (WHO) Adherence to Long-Term Therapies: Evidence for Action 2003, Available at: http://apps.who.int/iris/handle/10665/42682. Accessed: 2 October 2013, World Health Organization (WHO).
28. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL. Medication adherence issues in patients treated for COPD. Int J COPD 2008, 3:371-384.
29. Jäger L, Laurikainen K, Leinonen M, Silvasti M. Beclomethasone dipropionate Easyhaler is as effective as budesonide Turbuhaler in the control of asthma and is preferred by patients. German Study Group. Int J Clin Pract 2000, 54:368.
30. van Schayk CP, Bijl Hofland ID, Folgering H, Cloosterman SGM, Akkermans R, Elshout FVD, van Weel C. Influence of two different inhalation devices on therapy compliance in asthmatic patients. Scand J Prim Health Care 2002, 20:126.
31. Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft Mist™ Inhaler. Int J COPD 2009, 4:381-390.
32. George J, Kong DCM, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005, 128:3198-3204. 10.1378/chest.128.5.3198, 16304262.
33. Chapman KR, Fogarty CM, Peckitt C, Lassen C, Jadayel D, Dederichs J, Dalvi M, Kramer B. Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD. Int J COPD 2011, 6:353-363.
34. Anderson P. Patient preference for and satisfaction with inhaler devices. Eur Respir Rev 2005, 14:109-116.
35. Burnell PKP, Malton A, Reavill K, Ball MHE. Design, validation and initial testing of the Electronic Lung™ device. J Aerosol Sci 1998, 29:1011-1025.
36. Hamilton M, Prime D, Bogalo Huescar M, Pang C, Charles S, Gillett B. In-vitro delivery performance of umeclidinium and umeclidinium/vilanterol from a dry powder inhaler using the Electronic Lung breathing simulator to replicate inhalation profiles from patients with varying COPD severity. Am J Respir Crit Care Med 2013, 187:A4281.
37. Svedsater H, Jacques L, Goldfrad C, Bleecker ER, OByrne PM, Woodcock A. Ease of use of a two-strip dry powder inhaler (DPI) to deliver fluticasone furoate/vilanterol (FF/VI) and FF alone in asthma. Eur Respir J 2013, 42(Suppl 57):128s-129s.
38. Verver S, Poelman M, Bögels A, Chisholm SL, Dekker FW. Effects of instruction by practice assistants on inhaler technique and respiratory symptoms of patients. A controlled randomized videotaped intervention study. Fam Pract 1996, 13:35-40. 10.1093/fampra/13.1.35, 8671102.